Metopiron, Kapseln

7680278670148 CH-27867 Kapseln
Metopiron, Kapseln
Metopiron, Kapseln
Metopiron, Kapseln
1 / 3
google

Article details

Package size
50
Selling units
50
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
31/12/2024
Patient information leaflet
Français
31/12/2024
Patient information leaflet
Italien
31/12/2024
Summary of Product Characteristics
Allemand
31/12/2024
Summary of Product Characteristics
Français
31/12/2024
Summary of Product Characteristics
Italien
31/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
0.71 MG Substance HBESI
(N/A)
- Substance AIMDK
(N/A)
0.35 MG Substance HBESI
(N/A)
- Substance AROMA
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
0.13 MG Substance HBESI

Reimbursement information

Public price
CHF 317.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2015

Authorization holder

EffRx Pharmaceuticals SA

8807 Freienbach

Authorization information

Swissmedic authorization number
27867
Drug name
Metopiron, Kapseln
Galenic form
KAPWE
ATC Code
V04CD01
Authorization status
Z
Dispensing category
B
First authorization
14/06/1961
Authorization expiration date
31/12/9999
IT Number
07.07.4.
Domain
Human medicine
Field of application
Adrenocorticostaticum

Package details

Description (FR)
METOPIRONE caps 250 mg bte 50 pce
Description (DE)
METOPIRON Kaps 250 mg Ds 50 Stk
Market launch
14/06/1961
Narcotic (BTM)
No